Literature DB >> 1480852

The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.

E S Jaffe1, A Zarate-Osorno, L J Medeiros.   

Abstract

While Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) have long been regarded as distinct disease entities, recent observations suggest a closer association. The analysis of cases in which these diagnoses are made in the same anatomic site (composite lymphomas) or in separate sites (simultaneous or sequential HD and NHL) indicates that this phenomenon occurs more frequently than would be expected by chance alone. The most common form of composite lymphoma is coexistent nodular lymphocyte-predominant Hodgkin's disease (NLPHD) and large cell lymphoma (LCL) of B cell phenotype. This finding is consistent with a B cell origin for the abnormal cells in NLPHD, suggesting that LCL represents a form of histologic progression, with the existence of a clonal relationship between the two components. The association of other forms of HD (nodular sclerosis or mixed-cellularity) and NHL is less common, but still significant. As with NLPHD and LCL, one may observe composite lymphomas, or the diagnosis of HD may precede or follow the diagnosis of NHL. The vast majority of NHLs associated with HD are of B cell origin, most commonly follicular lymphomas. An association between HD and B cell chronic lymphocytic leukemia (CLL) is also observed. In selected cases, Reed-Sternberg (RS) cells are seen in a background of otherwise typical CLL, and some of these patients have progressed to disseminated HD. These findings suggest that, at least in some cases, HD may be clonally related to an underlying B cell malignancy, and that the RS cell may be an altered B lymphocyte.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1480852

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  16 in total

1.  Hodgkin's lymphoma developed after autologous stem cell transplantation for multiple myeloma: transformation or coincidental appearance?

Authors:  Istvan Kulcsar; Antonia Szanto; Laszlo Varoczy; Gabor Mehes; Margit Zeher
Journal:  Pathol Oncol Res       Date:  2011-11-24       Impact factor: 3.201

2.  Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000.

Authors:  T Mitterlechner; M Fiegl; H Mühlböck; W Oberaigner; S Dirnhofer; A Tzankov
Journal:  J Clin Pathol       Date:  2006-01       Impact factor: 3.411

3.  Coexisting and clonally identical classic hodgkin lymphoma and nodular lymphocyte predominant hodgkin lymphoma.

Authors:  Joo Y Song; Franziska C Eberle; Liqiang Xi; Mark Raffeld; Osama Rahma; Wyndham H Wilson; Kieron Dunleavy; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

4.  Taking gray zone lymphomas out of the shadows.

Authors:  Elías Campo; Elaine S Jaffe
Journal:  Blood       Date:  2021-04-01       Impact factor: 22.113

5.  Three coexisting lymphomas in one patient: genetically related or only a coincidence?

Authors:  M Steinhoff; C Assaf; I Anagnostopoulos; C C Geilen; H Stein; M Hummel
Journal:  J Clin Pathol       Date:  2006-12       Impact factor: 3.411

6.  Sequential occurrence of a splenic marginal zone lymphoma, extranodal MALT lymphoma, and Hodgkin lymphoma.

Authors:  Amer Zeidan; Bishoy Faltas; Patrick Forde; Andrea Subhawong; Celeste Bello; Javier Bolaños-Meade
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-06-05

Review 7.  Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?

Authors:  Cliona Grant; Kieron Dunleavy; Franziska C Eberle; Stefania Pittaluga; Wyndham H Wilson; Elaine S Jaffe
Journal:  Curr Hematol Malig Rep       Date:  2011-09       Impact factor: 3.952

8.  Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.

Authors:  Leticia Quintanilla-Martinez; Daphne de Jong; Antoine de Mascarel; Eric D Hsi; Philip Kluin; Yaso Natkunam; Marie Parrens; Stefano Pileri; German Ott
Journal:  J Hematop       Date:  2009-12-22       Impact factor: 0.196

Review 9.  Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?

Authors:  Kieron Dunleavy; Cliona Grant; Franziska C Eberle; Stefania Pittaluga; Elaine S Jaffe; Wyndham H Wilson
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

Review 10.  The Microscope as a Tool for Disease Discovery-A Personal Voyage.

Authors:  Elaine S Jaffe
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.